Christopher Bowden
CIK 1608601 · Chief Medical Officer · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$556.1K
Companies
5
Total Filings
44
Lifetime Open-Market Net
-$13.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCAX | Director | — | $21.69 | — | $0 | 2 | 2026-06-10 |
| TCRT | Director | 44,167 | $2.26 | $99.8K | $0 | 1 | 2022-06-24 |
| AGIO | Chief Medical Officer | 15,487 | $29.46 | $456.2K | -$13.23M | 35 | 2021-06-22 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 4,167 | $0.87 | $3.6K | $0 | 3 | 2021-05-06 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 3 | 2020-05-22 |
Recent Filings · Page 5 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-02-23 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2016-02-18 | AGIO | Grant (A) | — | $0 | EDGAR |
| 2015-06-02 | AGIO | Mixed | — | -$427.6K | EDGAR |
| 2015-03-03 | AGIO | Grant (A) | — | $0 | EDGAR |
Showing 41–44 of 44
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.